Lv1
44 积分 2023-10-07 加入
Treatment Decisions in Multiple Myeloma
6小时前
待确认
First-line Therapy in Newly Diagnosed Multiple Myeloma
6小时前
已完结
Redefining plasma cell leukaemia
19天前
已完结
Prognostic Implications of Measurable Residual Disease and Autologous Hematopoietic Stem Cell Transplantation in Primary Plasma Cell Leukemia in the Era of Novel Agents
3个月前
已完结
Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis
3个月前
已完结
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study
4个月前
已完结
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma
6个月前
已完结
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH)
7个月前
已关闭
Design, synthesis and biological evaluation of the thioether-containing lenalidomide analogs with anti-proliferative activities
7个月前
已完结
An erythroid-biased FOShi hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxia
7个月前
已完结
皖公网安备34019202002308
